SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Genomic Valley Biotech informs about newspaper publication

06 Jan 2020 Evaluate

Genomic Valley Biotech has informed that the Company enclosed herewith the Newspaper Advertisements published for the Closure of Trading Window for the Board Meeting to be held for the purpose of consideration and approval of the Un-Audited Financial Results for the quarter and nine months ended December 31, 2019 in the newspapers, Financial Express (English Edition) and Haribhoomi (Hindi Edition) on 1st January, 2020.

The above information is a part of company’s filings submitted to BSE.

Genomic Valley Share Price

28.80 1.35 (4.92%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1478.75
Mangalam Global Ent 12.55
Kaveri Seed 927.05
Regaal Resources 78.46
Simran Farms 156.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×